BioPharmSignal logoBioPharmSignal

Biotech News

Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting

Integra LifeSciences (IART)Integra LifeSciencesCompany update

PRINCETON, N.J., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced its participation in the 2026 Congress of Neurological Surgeons (CNS) Annual Meeting, taking place October 31-November 4 in Washington,

Related news

IARTIntegra LifeSciences2026-10-16 12:40 EST

Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting

IARTIntegra LifeSciences2026-09-25 13:05 EST

Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026

CVRXCVRx2026-09-29 20:30 EST

CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026

TMCITreace Medical Concepts2026-09-15 21:07 EST

Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting

STIMNeuronetics2026-09-08 12:32 EST

NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System

SGHTSight Sciences2026-10-01 11:05 EST

Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting

SGHTSight Sciences2026-11-04 21:05 EST

Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance

STIMNeuronetics2026-11-04 12:50 EST

Neuronetics Reports Third Quarter 2026 Financial and Operating Results

PAVMPAVmed2026-10-30 12:30 EST

PAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026

CVRXCVRx2026-10-22 20:30 EST

CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026

View all latest news

Integra LifeSciences

Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes. Neurosurgical Technologies The company supplies instruments, implants and...

Recent company news

IARTIntegra LifeSciences2026-11-06 13:00 EST

Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference

IARTIntegra LifeSciences2026-10-30 12:30 EST

Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting

IARTIntegra LifeSciences2026-10-21 10:00 EST

Integra LifeSciences Reports Third Quarter 2026 Financial Results

IARTIntegra LifeSciences2026-10-19 20:05 EST

Integra Announces Completion of Refinancing Transactions

IARTIntegra LifeSciences2026-10-16 12:40 EST

Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting

Stock data

Close
14.12 USD
Market cap
1.22B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States